Literature DB >> 9343217

The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

M K Njenga1, K Asakura, S F Hunter, P Wettstein, L R Pease, M Rodriguez.   

Abstract

Infection of susceptible strains of mice with Daniel's (DA) strains of Theiler's murine encephalomyelitis virus (DAV) results in virus persistence in the central nervous system (CNS) white matter and chronic demyelination similar to that observed in multiple sclerosis. We investigated whether persistence is due to the immune system more efficiently clearing DAV from gray than from white matter of the CNS. Severe combined immunodeficient (SCID) and immunocompetent C.B-17 mice were infected with DAV to determine the kinetics, temporal distribution, and tropism of the virus in CNS. In early disease (6 h to 7 days postinfection), DAV replicated with similar kinetics in the brains and spinal cords of SCID and immunocompetent mice and in gray and white matter. DAV RNA was localized within 48 h in CNS cells of all phenotypes, including neurons, oligodendrocytes, astrocytes, and macrophages/microglia. In late disease (13 to 17 days postinfection), SCID mice became moribund and permitted higher DAV replication in both gray and white matter. In contrast, immunocompetent mice cleared virus from the gray matter but showed replication in the white matter of their brains and spinal cords. Reconstitution of SCID mice with nonimmune splenocytes or anti-DAV antibodies after establishment of infection demonstrated that both cellular and humoral immune responses decreased virus from the gray matter; however, the cellular responses were more effective. SCID mice reconstituted with splenocytes depleted of CD4+ or CD8+ T lymphocytes cleared virus from the gray matter but allowed replication in the white matter. These studies demonstrate that both neurons and glia are infected early following DAV infection but that virus persistence in the white matter is due to preferential clearance of virus from the gray matter by the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343217      PMCID: PMC192323     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

2.  Theiler's virus replication in brain macrophages cultured in vitro.

Authors:  M Levy; C Aubert; M Brahic
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Genetic mapping of the ability of Theiler's virus to persist and demyelinate.

Authors:  A McAllister; F Tangy; C Aubert; M Brahic
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice.

Authors:  P Borrow; P Tonks; C J Welsh; A A Nash
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

5.  Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.

Authors:  M Rodriguez; A J Dunkel; R L Thiemann; J Leibowitz; M Zijlstra; R Jaenisch
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

6.  Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice.

Authors:  E Cash; M Chamorro; M Brahic
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

7.  Theiler's virus infection of beta 2-microglobulin-deficient mice.

Authors:  L Fiette; C Aubert; M Brahic; C P Rossi
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

Authors:  R J Clatch; R W Melvold; S D Miller; H L Lipton
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

10.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  30 in total

1.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

4.  Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection.

Authors:  Mary W Meagher; Robin R Johnson; Erin E Young; Elisabeth G Vichaya; Shannon Lunt; Elizabeth A Hardin; Marilyn A Connor; C Jane R Welsh
Journal:  Brain Behav Immun       Date:  2007-06-25       Impact factor: 7.217

5.  Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection.

Authors:  Erin E Young; Thomas W Prentice; Danielle Satterlee; Heath McCullough; Amy N Sieve; Robin R Johnson; Thomas H Welsh; C Jane R Welsh; Mary W Meagher
Journal:  Physiol Behav       Date:  2008-05-07

6.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

Review 7.  Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption.

Authors:  Holly L Johnson; Fang Jin; Istvan Pirko; Aaron J Johnson
Journal:  J Neurovirol       Date:  2013-07-16       Impact factor: 2.643

8.  Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.

Authors:  Kevin D Pavelko; Charles L Howe; Kristen M Drescher; Jeff D Gamez; Aaron J Johnson; Tao Wei; Richard M Ransohoff; Moses Rodriguez
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques.

Authors:  Rebecca LaRue; Suzanne Myers; Laurie Brewer; Daniel P Shaw; Corrie Brown; Bruce S Seal; M Kariuki Njenga
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases.

Authors:  F Levillayer; M Mas; F Levi-Acobas; M Brahic; J F Bureau
Journal:  Genetics       Date:  2007-05-04       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.